N/A; N/A
.
End stage kidney disease (ESKD) is a potentially fatal disease that can be treated by one of three modalities: dialysis (hemodialysis or peritoneal dialysis) and kidney transplantation. Either of these options represents a heavy burden on health systems. Kidney transplantation has its own financial framework. Dialysis care, provided by public or private institutions is funded, since 2008, by a prospective bundl...
Introduction: Elderly patients with chronic kidney disease (CKD) present a higher risk of becoming frail, a consequence of several comorbidities and worse functional status. This condition does not necessarily improve with the initiation of dialysis. Conservative care offers an option to treat elderly and/or frail patients with advanced CKD, which focuses on improving the patient’s quality of life, active sympt...
Patients with end‐stage renal disease (ESRD) have high morbidity and mortality rates compared to age‐matched individuals. The treatment for ESRD typically involves renal replacement therapies such as dialysis or kidney transplant. Despite the high comorbidity and frailty presented by the patients with ESRD, many of these individuals do not discuss their end‐of‐life preferences with loved ones or healthcare prov...
N/a.; N/a.
Introduction: There is a growing need to train nonpalliative physicians in palliative care, as it is increasingly recognized by the medical profession. Political and opinion leaders are also becoming aware of the urgent and growing need for palliative care education. Objective: The aim of this study is to provide an overview of the information available in the literature on the topic of palliative care competen...
The aging of the population has led to an increased prevalence of chronic diseases such as chronic kidney disease. Anemia is one of the most frequent complications of chronic kidney disease, with an impact not only on the quality of life but also on the patient’s prognosis and associated costs. Knowledge in this therapeutic area has increased significantly: from the appearance of recombinant erythropoietin in 1...